In vitro chemosensitivity test to predict chemosensitivity for paclitaxel, using human gastric carcinoma tissues

International Journal of Clinical Oncology

Volumn 11, Issue 6, 2006, Pages 449-453

  Kodera, Yasuhiro ^a   Ito, Seiji ^b   Fujiwara, Michitaka ^a   Mochizuki, Yoshinari ^b   Ohashi, Norifumi ^a   Ito, Yuichi ^a   Nakayama, Goro ^a   Koike, Masahiko ^a   Yamamura, Yoshitaka ^b   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chemotherapy; Drug response assay; Histoculture; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHEMOSENSITIVITY; CORRELATION ANALYSIS; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; STOMACH CARCINOMA; TISSUE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CULTURE TECHNIQUES; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 33845775285     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0618-x     Document Type: Article

References (21)

1. D Cunningham WH Alum SP Stenning 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Eng J Med 355 11 20
2. B Neri G Cini F Andreoli 2001 Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up Br J Cancer 84 878 880
3. L Cirera A Balil E Batiste-Alentorn 1999 Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer J Clin Oncol 17 3810 3815
4. JS Macdonald SR Smalley J Benedetti 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730
5. T Nakajima A Nashimoto M Kitamura 1999 Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial Lancet 354 273 277
6. A Nashimoto T Nakajima H Furukawa 2003 Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1 J Clin Oncol 21 2282 2287
7. I Miyashiro H Furukawa M Sasako 2005 No survival benefit with adjuvant chemotherapy for serosa-positive gastric cancer: randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil in serosa-positive gastric cancer. Japan Clinical Oncology Group 9206-2 Proc ASCO-GI 84 4
8. K Iwao-Koizumi R Matoba N Ueno 2005 Prediction of docetaxel response in human breast cancer by gene expression profiling J Clin Oncol 23 422 431
9. R Luthra TT Wu MG Luthra 2006 Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation J Clin Oncol 24 259 267
10. DJ Samson J Seidenfeld K Ziegler 2004 Chemotherapy sensitivity and resistance assays: a systematic review J Clin Oncol 22 3618 3630
11. S Suda S Akiyama H Sekiguchi 2002 Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents Surgery Today 32 477 481
12. nd English edition Gastric Cancer 1 10 24
13. S Maeda Y Saikawa T Kubota 2003 No cross-resistance of Taxotere and Taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay Anticancer Res 23 314 3150
14. EK Rowinsky RC Donehower RJ Jones 1988 Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol Cancer Res 48 4093 4100
15. H Kobayashi 2005 Collagen gel droplet culture method to examine in vitro chemosensitivity Methods Mol Med 110 59 67
16. K Yamaguchi M Tada N Horikoshi 2002 Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer Gastric Cancer 5 90 95
17. Y Sakata A Ohtsu N Horikoshi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
18. H Nakanishi Y Mochizuki Y Kodera 2003 Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line Cancer Sci 94 112 118
19. N Ohashi Y Kodera H Nakanishi 2005 Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice Int J Oncol 27 637 644
20. S Abe T Kubota SW Matsuzaki 1999 Chemosensitivity test is useful in evaluating the appropriate adjuvant cancer chemotherapy for stage III non-scirrhous and scirrhous gastric cancers Anticancer Res 19 4581 4586
21. A Tsuburaya J Sakamoto S Morita 2005 A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S-1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial Jpn J Clin Oncol 35 672 675